OS Therapies Incorporated
OSTX
$2.42
$0.08743.75%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -36.61% | 76.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.22% | 68.54% | |||
| Operating Income | 3.22% | -68.54% | |||
| Income Before Tax | -17.02% | -29.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.02% | -29.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.02% | -29.61% | |||
| EBIT | 3.22% | -68.54% | |||
| EBITDA | 5.45% | -68.59% | |||
| EPS Basic | 0.99% | 20.04% | |||
| Normalized Basic EPS | 0.96% | -32.71% | |||
| EPS Diluted | 0.99% | 20.04% | |||
| Normalized Diluted EPS | 0.96% | -32.71% | |||
| Average Basic Shares Outstanding | 18.19% | -2.34% | |||
| Average Diluted Shares Outstanding | 18.19% | -2.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||